Contribution: Industrial Research Assistance Program – Contributions to Firms
Sciences Cinq Prime Incorporée/Five Prime Sciences Incorporated
$75,000.00
MNC Collab- Autoimmune-Protect - Novel protective targets for autoimmune diseases
FY 2024-25 · 2024-12-09
Summary
As part of Multinational Corporate Collaboration Program, the project "Novel protective targets for outoimmune diseases" will focus on developing genomics methods to identify drug targets that causally influence autoimmune diseases.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Location
Westmount|Westmount, Quebec, Canada
Recipient Type
For-profit organization
Business Number
784295503
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2024-12-09 | 2024-25 | $50,000.00 |
| 2 | 2024-12-09 | 2024-25 | $75,000.00 |
As published
Additional Information
This agreement has been amended 2 time(s). The end date of this agreements has been modified by 105 days. The total amended value is 25,000 dollars.
Additional Information (French)
Cet accord a été modifié 2 fois La date de fin du présent accord a été changé de 105 jours. La valeur totale des modifications est de 25 000 dollars.
Agreement End Date
2025-09-26
Agreement Number
1026335
Agreement Start Date
2024-12-09
Agreement Title
MNC Collab- Autoimmune-Protect - Novel protective targets for autoimmune diseases
Agreement Title (French)
PCM - Auto-immunité - Nouvelles cibles de protection pour les maladies auto-immunes
Agreement Type
Contribution
Agreement Value
$75,000.00
Amendment Date
2025-05-26
Amendment Number
2
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
As part of Multinational Corporate Collaboration Program, the project "Novel protective targets for outoimmune diseases" will focus on developing genomics methods to identify drug targets that causally influence autoimmune diseases.
Description (French)
Dans le cadre du programme de collaboration des entreprises multinationales, le projet Cibler de nouvelles cibles de protection pour les maladies auto-immunes se concentrera sur le développement de méthodes génomiques pour identifier les cibles médicamenteuses qui influencent de manière causale les maladies auto-immunes.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Notre-Dame-de-Grâce--Westmount
Federal Riding (French)
Notre-Dame-de-Grâce--Westmount
Federal Riding Number
24053
NAICS Code
541710
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
784295503
Recipient City
Westmount|Westmount
Recipient Country
CA
Recipient Legal Name
Sciences Cinq Prime Incorporée/Five Prime Sciences Incorporated
Recipient Postal Code
H3Y 2W4
Recipient Province or Territory
QC
Recipient Type
F
Reference Number
172-2024-2025-Q4-1026335
